TGR1202
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TGR1202, covering 2021-07-16 to 2021-07-16. Get the full timeline:
Most recent: Clinical Trial Update: TGR1202 in Relapsed and Refractory Follicular Lymphoma [Phase 2]